KYMR
Price
$63.63
Change
+$0.10 (+0.16%)
Updated
Nov 13 closing price
Capitalization
4.58B
97 days until earnings call
Intraday BUY SELL Signals
TBPH
Price
$17.95
Change
+$0.17 (+0.96%)
Updated
Nov 13 closing price
Capitalization
908.56M
108 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KYMR vs TBPH

Header iconKYMR vs TBPH Comparison
Open Charts KYMR vs TBPHBanner chart's image
Kymera Therapeutics
Price$63.63
Change+$0.10 (+0.16%)
Volume$1.01M
Capitalization4.58B
Theravance Biopharma
Price$17.95
Change+$0.17 (+0.96%)
Volume$817.92K
Capitalization908.56M
KYMR vs TBPH Comparison Chart in %
View a ticker or compare two or three
VS
KYMR vs. TBPH commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and TBPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (KYMR: $63.53 vs. TBPH: $17.78)
Brand notoriety: KYMR and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 115% vs. TBPH: 200%
Market capitalization -- KYMR: $4.58B vs. TBPH: $908.56M
KYMR [@Biotechnology] is valued at $4.58B. TBPH’s [@Biotechnology] market capitalization is $908.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileTBPH’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • TBPH’s FA Score: 0 green, 5 red.
According to our system of comparison, both KYMR and TBPH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 3 TA indicator(s) are bullish while TBPH’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 3 bullish, 5 bearish.
  • TBPH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TBPH is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а +6.08% price change this week, while TBPH (@Biotechnology) price change was +18.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 19, 2026.

TBPH is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.58B) has a higher market cap than TBPH($909M). TBPH YTD gains are higher at: 88.948 vs. KYMR (57.917). TBPH has higher annual earnings (EBITDA): 46.1M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. TBPH (339M). TBPH has less debt than KYMR: TBPH (46.5M) vs KYMR (85.7M). TBPH has higher revenues than KYMR: TBPH (77.2M) vs KYMR (44.7M).
KYMRTBPHKYMR / TBPH
Capitalization4.58B909M504%
EBITDA-267.03M46.1M-579%
Gain YTD57.91788.94865%
P/E RatioN/A31.46-
Revenue44.7M77.2M58%
Total Cash665M339M196%
Total Debt85.7M46.5M184%
FUNDAMENTALS RATINGS
TBPH: Fundamental Ratings
TBPH
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
80
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
88
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRTBPH
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 23 days ago
87%
Bearish Trend 7 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signal:
Gain/Loss:
TBPH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRISX48.440.54
+1.13%
T. Rowe Price Financial Services
AIHHX7.190.01
+0.14%
Aristotle Small/Mid Cap Equity I-2
TRGLX77.010.08
+0.10%
T. Rowe Price Global Stock I
FMFEX88.87N/A
N/A
Fidelity Advisor Materials I
OTPIX53.51-0.04
-0.07%
ProFunds NASDAQ-100 Inv

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.25%
NRIX - KYMR
64%
Loosely correlated
-5.37%
VERA - KYMR
60%
Loosely correlated
+4.61%
NUVL - KYMR
55%
Loosely correlated
+0.91%
CGON - KYMR
54%
Loosely correlated
+1.47%
IDYA - KYMR
54%
Loosely correlated
-0.19%
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with KYMR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
-3.89%
KYMR - TBPH
48%
Loosely correlated
+0.25%
VYGR - TBPH
40%
Loosely correlated
-0.23%
VERA - TBPH
37%
Loosely correlated
+4.61%
AXON - TBPH
34%
Loosely correlated
-0.47%
ARRY - TBPH
34%
Loosely correlated
-8.69%
More